Serban Dan Costa

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.6K citations

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Gϋnter von Minckwitz, Andreas Schneeweiß, Sibylle Loibl et al. · The Lancet Oncology · 2014 · 1K citations

Gbg 66, Breast Oncology, Medicine +7

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa et al. · New England Journal of Medicine · 1998 · 808 citations · Full text

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Michael Untch, Mahdi Rezai, Sibylle Loibl et al. · Journal of Clinical Oncology · 2010 · 550 citations · Full text

Surgical Oncology, Oncology, High Pcr Rate +13

Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status

Ingo Diel, M. Kaufmann, Serban Dan Costa et al. · JNCI Journal of the National Cancer Institute · 1996 · 487 citations